{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:01:13Z","timestamp":1778871673375,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00395-015-0504-7","type":"journal-article","created":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T07:36:10Z","timestamp":1437550570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor"],"prefix":"10.1007","volume":"110","author":[{"given":"Gabriela Placon\u00e1","family":"Diniz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline Antunes","family":"Lino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Castilho","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana do","family":"Nascimento Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza Morais","family":"Barreto-Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,23]]},"reference":[{"key":"504_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.109.212183","volume":"106","author":"M Abdellatif","year":"2010","unstructured":"Abdellatif M (2010) The role of microR-133 in cardiac hypertrophy uncovered. Circ Res 106:16\u201318. doi: 10.1161\/CIRCRESAHA.109.212183","journal-title":"Circ Res"},{"key":"504_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.RES.69.2.266","volume":"69","author":"M Arai","year":"1991","unstructured":"Arai M, Otsu K, MacLennan DH, Alpert NR, Periasamy M (1991) Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res 69:266\u2013276. doi: 10.1161\/01.RES.69.2.266","journal-title":"Circ Res"},{"key":"504_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1590\/S0100-879X2000000600007","volume":"33","author":"ML Barreto-Chaves","year":"2000","unstructured":"Barreto-Chaves ML, Heimann A, Krieger JE (2000) Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Braz J Med Biol Res 33:661\u2013664. doi: 10.1590\/S0100-879X2000000600007","journal-title":"Braz J Med Biol Res"},{"key":"504_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrendo.2010.105","volume":"6","author":"B Biondi","year":"2010","unstructured":"Biondi B, Kahaly GJ (2010) Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6:431\u2013443. doi: 10.1038\/nrendo.2010.105","journal-title":"Nat Rev Endocrinol"},{"key":"504_CR5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","volume":"167","author":"B Biondi","year":"2012","unstructured":"Biondi B (2012) Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol 167:609\u2013618. doi: 10.1530\/EJE-12-0627","journal-title":"Eur J Endocrinol"},{"key":"504_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Car\u00e8","year":"2007","unstructured":"Car\u00e8 A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, H\u00f8ydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613\u2013618. doi: 10.1038\/nm1582","journal-title":"Nat Med"},{"key":"504_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00395-010-0089-0","volume":"105","author":"MS Carneiro-Ramos","year":"2010","unstructured":"Carneiro-Ramos MS, Diniz GP, Nadu AP, Almeida J, Vieira RL, Santos RA, Barreto-Chaves ML (2010) Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation. Basic Res Cardiol 105:325\u2013335. doi: 10.1007\/s00395-010-0089-0","journal-title":"Basic Res Cardiol"},{"key":"504_CR8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/jcp.22939","volume":"227","author":"G Castoldi","year":"2012","unstructured":"Castoldi G, Di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini G, Condorelli G, Stella A (2012) MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J Cell Physiol 227:850\u2013856. doi: 10.1002\/jcp.22939","journal-title":"J Cell Physiol"},{"key":"504_CR9","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1172\/JCI119699","volume":"100","author":"KC Chang","year":"1997","unstructured":"Chang KC, Figueredo VM, Schreur JH, Kariya K, Weiner MW, Simpson PC, Camacho SA (1997) Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts. J Clin Invest 100:1742\u20131749. doi: 10.1172\/JCI119699","journal-title":"J Clin Invest"},{"key":"504_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","volume":"15","author":"W Dillmann","year":"2010","unstructured":"Dillmann W (2010) Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev 15:125\u2013132. doi: 10.1007\/s10741-008-9125-7","journal-title":"Heart Fail Rev"},{"key":"504_CR11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","volume":"104","author":"GP Diniz","year":"2009","unstructured":"Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML (2009) Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway. Basic Res Cardiol 104:653\u2013667. doi: 10.1007\/s00395-009-0043-1","journal-title":"Basic Res Cardiol"},{"key":"504_CR12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/JME-11-0141","volume":"49","author":"GP Diniz","year":"2012","unstructured":"Diniz GP, Takano AP, Bruneto E, Silva FG, Nunes MT, Barreto-Chaves ML (2012) New insight into the mechanisms associated with the rapid effect of T3 on AT1R expression. J Mol Endocrinol 49:11\u201320. doi: 10.1530\/JME-11-0141","journal-title":"J Mol Endocrinol"},{"key":"504_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mce.2013.04.010","volume":"374","author":"GP Diniz","year":"2013","unstructured":"Diniz GP, Takano AP, Barreto-Chaves ML (2013) MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy\u2014role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a\/\u03b1-MHC modulation. Mol Cell Endocrinol 374:117\u2013124. doi: 10.1016\/j.mce.2013.04.010","journal-title":"Mol Cell Endocrinol"},{"key":"504_CR14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0008-6363(02)00661-2","volume":"57","author":"D Dong","year":"2003","unstructured":"Dong D, Duan Y, Guo J, Roach DE, Swirp SL, Wang L, Lees-Miller JP, Sheldon RS, Molkentin JD, Duff HJ (2003) Overexpression of calcineurin in mouse causes sudden cardiac death associated with decreased density of K+ channels. Cardiovasc Res 57:320\u2013332. doi: 10.1016\/S0008-6363(02)00661-2","journal-title":"Cardiovasc Res"},{"key":"504_CR15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/HYPERTENSIONAHA.109.139519","volume":"55","author":"DL Dong","year":"2010","unstructured":"Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF (2010) Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55:946\u2013952. doi: 10.1161\/HYPERTENSIONAHA.109.139519","journal-title":"Hypertension"},{"key":"504_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11886-010-0096-7","volume":"12","author":"GW Dorn 2nd","year":"2010","unstructured":"Dorn GW 2nd (2010) Therapeutic potential of microRNAs in heart failure. Curr Cardiol Rep 12:209\u2013215. doi: 10.1007\/s11886-010-0096-7","journal-title":"Curr Cardiol Rep"},{"key":"504_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","volume":"104","author":"RF Duisters","year":"2009","unstructured":"Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104:170\u2013178. doi: 10.1161\/CIRCRESAHA.108.182535 (6p following 178)","journal-title":"Circ Res"},{"key":"504_CR18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.lfs.2011.01.009","volume":"88","author":"JC Ferreira","year":"2011","unstructured":"Ferreira JC, Moreira JB, Campos JC, Pereira MG, Mattos KC, Coelho MA, Brum PC (2011) Angiotensin receptor blockade improves the net balance of cardiac Ca(2+) handling-related proteins in sympathetic hyperactivity-induced heart failure. Life Sci 88:578\u2013585. doi: 10.1016\/j.lfs.2011.01.009","journal-title":"Life Sci"},{"key":"504_CR19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.112.000882","volume":"127","author":"J Ganesan","year":"2013","unstructured":"Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B, Engelhardt S (2013) MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation 127:2097\u20132106. doi: 10.1161\/CIRCULATIONAHA.112.000882","journal-title":"Circulation"},{"key":"504_CR20","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.00269.2003","volume":"285","author":"LW Hu","year":"2003","unstructured":"Hu LW, Benvenuti LA, Liberti EA, Carneiro-Ramos MS, Barreto-Chaves ML (2003) Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol 285:R1473\u2013R1480. doi: 10.1152\/ajpregu.00269.2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"504_CR21","doi-asserted-by":"crossref","first-page":"e29173","DOI":"10.1371\/journal.pone.0029173","volume":"6","author":"MB Huang","year":"2011","unstructured":"Huang MB, Xu H, Xie SJ, Zhou H, Qu LH (2011) Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One 6:e29173. doi: 10.1371\/journal.pone.0029173","journal-title":"PLoS One"},{"key":"504_CR22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCRESAHA.112.300682","volume":"112","author":"ZP Huang","year":"2013","unstructured":"Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, Wang DZ (2013) MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ Res 112:1234\u20131243. doi: 10.1161\/CIRCRESAHA.112.300682","journal-title":"Circ Res"},{"key":"504_CR23","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1074\/jbc.M512671200","volume":"281","author":"A Kenessey","year":"2006","unstructured":"Kenessey A, Ojamaa K (2006) Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281:20666\u201320672. doi: 10.1074\/jbc.M512671200","journal-title":"J Biol Chem"},{"key":"504_CR24","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S (2007) Thyroid disease and the heart. Circulation 116:1725\u20131735. doi: 10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"504_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1677\/joe.0.1600043","volume":"160","author":"H Kobori","year":"1999","unstructured":"Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T (1999) Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160:43\u201347. doi: 10.1677\/joe.0.1600043","journal-title":"J Endocrinol"},{"key":"504_CR26","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/en.2007-0099","volume":"148","author":"JA Kuzman","year":"2007","unstructured":"Kuzman JA, O\u2019Connell TD, Gerdes AM (2007) Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148:3477\u20133484. doi: 10.1210\/en.2007-0099","journal-title":"Endocrinology"},{"key":"504_CR27","doi-asserted-by":"crossref","first-page":"15073","DOI":"10.1074\/jbc.M207593200","volume":"278","author":"F Liang","year":"2003","unstructured":"Liang F, Webb P, Marimuthu A, Zhang S, Gardner DG (2003) Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 278:15073\u201315083. doi: 10.1074\/jbc.M207593200","journal-title":"J Biol Chem"},{"key":"504_CR28","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.1074\/jbc.M801035200","volume":"283","author":"X Luo","year":"2008","unstructured":"Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z (2008) Down-regulation of miR-1\/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 283:20045\u201320052. doi: 10.1074\/jbc.M801035200","journal-title":"J Biol Chem"},{"key":"504_CR29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW 2nd (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106:166\u2013175. doi: 10.1161\/CIRCRESAHA.109.202176","journal-title":"Circ Res"},{"key":"504_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","volume":"93","author":"JD Molkentin","year":"1998","unstructured":"Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215\u2013228. doi: 10.1016\/S0092-8674(00)81573-1","journal-title":"Cell"},{"key":"504_CR31","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.111.030932","volume":"124","author":"RL Montgomery","year":"2011","unstructured":"Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124:1537\u20131547. doi: 10.1161\/CIRCULATIONAHA.111.030932","journal-title":"Circulation"},{"key":"504_CR32","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1073\/pnas.86.8.2966","volume":"86","author":"R Nagai","year":"1989","unstructured":"Nagai R, Zarain-Herzberg A, Brandl CJ, Fujii J, Tada M, MacLennan DH, Alpert NR, Periasamy M (1989) Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 86:2966\u20132970. doi: 10.1073\/pnas.86.8.2966","journal-title":"Proc Natl Acad Sci USA"},{"key":"504_CR33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1055\/s-2005-870317","volume":"37","author":"C Pantos","year":"2005","unstructured":"Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV (2005) Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm Metab Res 37:500\u2013504. doi: 10.1055\/s-2005-870317","journal-title":"Horm Metab Res"},{"key":"504_CR34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00395-013-0361-1","volume":"108","author":"R Papait","year":"2013","unstructured":"Papait R, Greco C, Kunderfranco P, Latronico MV, Condorelli G (2013) Epigenetics: a new mechanism of regulation of heart failure? Basic Res Cardiol 108:361. doi: 10.1007\/s00395-013-0361-1","journal-title":"Basic Res Cardiol"},{"key":"504_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/cvr\/cvm056","volume":"77","author":"M Periasamy","year":"2008","unstructured":"Periasamy M, Bhupathy P, Babu GJ (2008) Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res 77:265\u2013273. doi: 10.1093\/cvr\/cvm056","journal-title":"Cardiovasc Res"},{"key":"504_CR36","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/physiolgenomics.00145.2010","volume":"43","author":"UP Soci","year":"2011","unstructured":"Soci UP, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, Rosa KT, Irigoyen MC, Phillips MI, Oliveira EM (2011) MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 43:665\u2013673. doi: 10.1152\/physiolgenomics.00145.2010","journal-title":"Physiol Genomics"},{"key":"504_CR37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1871530311313010005","volume":"13","author":"V Triggiani","year":"2013","unstructured":"Triggiani V, Iacoviello M (2013) Thyroid disorders in chronic heart failure: from prognostic set-up to therapeutic management. Endocr Metab Immune Disord Drug Targets 13:22\u201337. doi: 10.2174\/1871530311313010005#sthash.EqpF9lWp.dpuf","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"504_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/cvr\/cvn137","volume":"79","author":"T Thum","year":"2008","unstructured":"Thum T, Catalucci D, Bauersachs J (2008) MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res 79:562\u2013570. doi: 10.1093\/cvr\/cvn137","journal-title":"Cardiovasc Res"},{"key":"504_CR39","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/ncomms2090","volume":"3","author":"A Ucar","year":"2012","unstructured":"Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, Dangwal S, Kumarswamy R, Bang C, Holzmann A, Remke J, Caprio M, Jentzsch C, Engelhardt S, Geisendorf S, Glas C, Hofmann TG, Nessling M, Richter K, Schiffer M, Carrier L, Napp LC, Bauersachs J, Chowdhury K, Thum T (2012) The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3:1078. doi: 10.1038\/ncomms2090","journal-title":"Nat Commun"},{"key":"504_CR40","doi-asserted-by":"crossref","first-page":"18255","DOI":"10.1073\/pnas.0608791103","volume":"103","author":"E Rooij van","year":"2006","unstructured":"van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103:18255\u201318260. doi: 10.1073\/pnas.0608791103","journal-title":"Proc Natl Acad Sci USA"},{"key":"504_CR41","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/hrt.2010.220418","volume":"97","author":"AV Villar","year":"2011","unstructured":"Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, Garc\u00eda R, Mart\u00edn-Dur\u00e1n R, Hurl\u00e9 JM, Hurl\u00e9 MA, Nistal JF (2011) Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis. Heart 97:1132\u20131137. doi: 10.1136\/hrt.2010.220418","journal-title":"Heart"},{"key":"504_CR42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/cr.2011.132","volume":"22","author":"J Wang","year":"2012","unstructured":"Wang J, Song Y, Zhang Y, Xiao H, Sun Q, Hou N, Guo S, Wang Y, Fan K, Zhan D, Zha L, Cao Y, Li Z, Cheng X, Zhang Y, Yang X (2012) Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice. Cell Res 22:516\u2013527. doi: 10.1038\/cr.2011.132","journal-title":"Cell Res"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-015-0504-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-015-0504-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-015-0504-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:44:37Z","timestamp":1559047477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-015-0504-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,23]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["504"],"URL":"https:\/\/doi.org\/10.1007\/s00395-015-0504-7","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,23]]},"article-number":"49"}}